Emergency balversa
Ended Awarded Last action
- Contract number
- 36C26224F0040
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $62,166
Award facts
- Contract value 100% obligated
- $62,165.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$65,682 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $127,847 |
About this award
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., for the provision of the cancer treatment drug BALVERSA. The $62,165.78 contract was awarded on October 5, 2023 under Janssen's Pharmaceuticals and Drugs schedule contract (FSS-61-IB) with the General Services Administration. The delivery order, which has a completion date of March 31, 2024, will support the procurement of BALVERSA for VA medical facilities across Veterans Integrated Service Network 22 in Texas and surrounding states. As a manufacturer of pharmaceutical goods, Janssen holds various blanket purchase agreements and schedule contracts with the VA to provide critical oncology medications to veterans receiving cancer care through the VHA system.
Quick answers
Who was awarded contract 36C26224F0040?
36C26224F0040 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 5, 2023.
How much is contract 36C26224F0040 worth?
The government has obligated $62,166 on 36C26224F0040.
Is contract 36C26224F0040 an order under another contract?
Yes. 36C26224F0040 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26224F0040 competed?
The extent of competition for 36C26224F0040 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award